CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

Share this content:
CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016
CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

WEDNESDAY, April 25, 2018 (HealthDay News) -- From 2000 to 2016 there was a decrease in the birth rate for U.S. females aged 10 to 14 years, according to an April data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS).

T.J. Mathews and Brady E. Hamilton, Ph.D., from the NCHS in Hyattsville, Md., describe recent trends and variations in births to young mothers aged 10 to 14 years by race, Hispanic origin, and state. Data were obtained from the National Vital Statistics System.

The researchers found that in 2015 and 2016, the birth rate for females aged 10 to 14 years reached a record low, at 0.2 births per 1,000 females, down from 0.9 in 2000. There was a decrease in the number of births to females aged 10 to 14 years, from 8,519 in 2000 to a record low of 2,253 in 2016. Birth rates declined for females aged 10 to 12, 13, and 14 years during 2000 to 2016. During the same time period, birth rates declined for females aged 10 to 14 years for all race and Hispanic-origin groups, with non-Hispanic black females having the largest decline. Delaware, Louisiana, and Mississippi had the highest birth rates for females aged 10 to 14 years for 2014 to 2016.

"The decline in birth rates for those aged 10 to 14 was greater from 2008 through 2016 than from 2000 through 2008, and these declines were broad-based," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »